Copyright
©The Author(s) 2017.
World J Hepatol. Jan 28, 2017; 9(3): 131-138
Published online Jan 28, 2017. doi: 10.4254/wjh.v9.i3.131
Published online Jan 28, 2017. doi: 10.4254/wjh.v9.i3.131
Mean ± SD (mL/min) | Range (mL/min) | Mean % error | P value | ||
DTPA | All | 111 ± 46 | 45-256 | ||
≤ 100 mL/min | 77 ± 14 | 45-96 | |||
> 100 mL/min | 140 ± 45 | 103-256 | |||
CG (no rounding) | All | 117 ± 38 | 55-207 | 12.9 | 0.352 |
≤ 100 mL/min | 98 ± 28 | 55-152 | 29.2 | 0.024 | |
> 100 mL/min | 135 ± 38 | 86-207 | -0.1 | 0.631 | |
CG (rounding SCr to 0.6 mg/dL) | All | 97 ± 30 | 46-172 | -7.0 | 0.029 |
≤ 100 mL/min | 82 ± 23 | 46-127 | 7.9 | 0.543 | |
> 100 mL/min | 110 ± 29 | 72-172 | -18.9 | 0.003 |
- Citation: Scappaticci GB, Regal RE. Cockcroft-Gault revisited: New de-liver-ance on recommendations for use in cirrhosis. World J Hepatol 2017; 9(3): 131-138
- URL: https://www.wjgnet.com/1948-5182/full/v9/i3/131.htm
- DOI: https://dx.doi.org/10.4254/wjh.v9.i3.131